The European Medicines Agency (EMA) will relocate to Amsterdam in the Netherlands.
The Agency now has just over 16 months to prepare for the move and take up its operations in Amsterdam on 30 March 2019 at the latest.
What is the impact for medical device manufacturers?
For consultation procedures under the MDD and under the MDR, it is part of the conformity assessment procedure with the notified by to contact either the local Authority or the EMA.
More concerning the relocation details can be found on EMA website.